The Gradinaru Research Group at Caltech studies the mechanism of action for deep brain stimulation (DBS), a therapeutical option for motor and mood disorders such as Parkinson's and depression. Dr. Gradinaru's previous work at Stanford developed and applied optogenetics (cell-type specific bi-directional control of neuronal activity with light) to animal models of Parkinson's to gain a mechanistic understanding of DBS. Her studies highlighted the importance of selectively controlling axons and not local cell bodies in modulating behavior, a principle that might play a generalized role across many effective DBS paradigms. In addition to ameliorating motor symptoms in Parkinson's disease, DBS might also aid long-term cell viability by regulating perturbed excitatory activity and promoting growth factor release. Therefore the group is now particularly interested in the long-term effects of DBS on neuronal health, function, and ultimately behavior.
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To aid this process, Dr. Gradinaru's group continues to develop tools and methods for neuroscience
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